Clinical Trial Update: Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study [NA]

View source ↗

Summary

A pilot study investigates downstaging unresectable hepatocellular carcinoma to resectable disease using a combination of immunotherapy and stereotactic radioth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: The University of Hong Kong | Conditions: HCC - Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma | NA | Status: RECRUITING